1 year ago, the approval of BRINSUPRI changed the bronchiectasis treatment landscape Watch videonext icon
Page header background

Marking 1 year
With Brinsupri
(brensocatib)

The first and only FDA-approved treatment specifically for non-cystic fibrosis bronchiectasis

1 year ago, people living with bronchiectasis woke up to a different treatment option: BRINSUPRI. Since its approval:

More than

26,000

people have been treated with BRINSUPRIa

Over

6,300

doctors have prescribed BRINSUPRIb

Watch to learn more about this milestone

On August 12, 2025,…

…people living with bronchiectasis woke up to a different treatment option.

[onscreen text] Actor portrayal.

Something that changed the bronchiectasis treatment landscape.

Once-daily BRINSUPRI became the first and only FDA-approved treatment...

[onscreen text] ONCE-DAILY

[onscreen text] THE FIRST AND ONLY FDA-APPROVED TREATMENT

[onscreen text] BRINSUPRI is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older.

[onscreen text] Please stay tuned for Important Safety Information at the end of this video.

...specifically for non-cystic fibrosis bronchiectasis in people 12 years and older.

[onscreen text] SPECIFICALLY FOR NON-CYSTIC FIBROSIS BRONCHIECTASIS

Since its approval, more than 26,000 people have been treated with BRINSUPRI.

[onscreen text] MORE THAN 26,000 PEOPLE HAVE BEEN TREATED WITH BRINSUPRI

[onscreen text] Treated patients have received at least 1 shipment of BRINSUPRI. Based on US data on file as of June 30, 2026.

Over 6,300 doctors have prescribed BRINSUPRI.

[onscreen text] OVER 6,300 DOCTORS HAVE PRESCRIBED BRINSUPRI

[onscreen text] Doctors have prescribed at least 1 prescription for BRINSUPRI for a patient. Based on US data on file as of June 30, 2026.

It's time to celebrate one year with BRINSUPRI...

[onscreen text] 1 YEAR WITH BRINSUPRI

...because the future of bronchiectasis treatment isn't something you're waiting for anymore.

If you or a loved one is living with bronchiectasis, learn more about BRINSUPRI at BRINSUPRI.com.

[onscreen text] LEARN MORE AT BRINSUPRI.COM

Insmed remains committed to supporting the bronchiectasis community.

BRINSUPRI offers you a different approach to treating bronchiectasis

Learn more

aTreated patients have received at least 1 shipment of BRINSUPRI. Based on US data on file as of June 30, 2026.
bDoctors have prescribed at least 1 prescription for BRINSUPRI for a patient. Based on US data on file as of June 30, 2026.

IMPORTANT SAFETY INFORMATION AND INDICATION

Before taking BRINSUPRI, tell your healthcare provider about all of your medical conditions, including if you:

  • have recently received or are scheduled to receive any live attenuated vaccinations.

  • are pregnant or plan to become pregnant. It is not known if BRINSUPRI will harm your unborn baby.

  • are breastfeeding or plan to breastfeed. It is not known if BRINSUPRI passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Do not change or stop your medicines unless your healthcare provider tells you to.

BRINSUPRI may cause serious side effects including:

  • Skin problems. Tell your healthcare provider about any new skin symptoms. Your healthcare provider may send you to a dermatologist for an examination, if needed. 

  • Dental problems. Get regular dental checkups while taking BRINSUPRI. Brush and clean your teeth as recommended by your dentist. Tell your healthcare provider and contact your dentist if you experience new gum (gingival) or teeth (dental) symptoms.

Common side effects of BRINSUPRI

The most common side effects of BRINSUPRI include upper respiratory tract infection, headache, rash, dry skin, small areas of skin thickening (hyperkeratosis), and high blood pressure (hypertension).

Less common side effects include abnormal liver blood test, hair loss (alopecia), and skin cancers.

These are not all of the possible side effects of BRINSUPRI.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

What is BRINSUPRI?

BRINSUPRI is a prescription medicine used to treat non-cystic fibrosis bronchiectasis (NCFB) in adults and children 12 years of age and older. It is not known if BRINSUPRI is safe and effective in children under 12 years of age.

Please see full Prescribing Information and Patient Information.